1
|
Sasse J, Pilhatsch M, Forsthoff A, Grunze H, Neutze J, Pfennig A, Schmitz B, Schwenkhagen A, Bauer M. [Specific aspects of treatment for women with bipolar affliction]. Nervenarzt 2009; 80:263-72. [PMID: 19229511 DOI: 10.1007/s00115-008-2644-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
This manuscript summarizes specific issues in the disease course and pharmacological treatment of women with bipolar disorders. Gender differences relevant to the female biology manifest in symptoms, outcome, and course. The preponderance of depressive symptoms is typical, and the risk of rapid cycling is estimated to be eight times higher for women than for men. Comorbid anxiety and eating disorders occur more frequently in female patients. In planning treatment it is important to take fertility, contraception, and pregnancy into consideration and adjust the pharmacotherapy to harmonize with the patient's current phase of life. Little is known about potential sexual dysfunctions of bipolar women. Further research should include clinical and observational studies focusing on gender-specific differences in symptomatology, treatment, and long-term outcome of bipolar disorders.
Collapse
Affiliation(s)
- J Sasse
- Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universitätsklinikum Carl Gustav Carus, Technische Universität, Fetscherstrasse 74, 01307, Dresden, Deutschland
| | | | | | | | | | | | | | | | | |
Collapse
|
2
|
Grunze H, Forsthoff A. [Bipolar disorders]. MMW Fortschr Med 2008; 150 Suppl 2:37-40. [PMID: 18678050 DOI: pmid/18678050] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Affiliation(s)
- H Grunze
- Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
| | | |
Collapse
|
3
|
Scheuerecker J, Zipse M, Ufer S, Wiesmann M, Zetzsche T, Frodl T, Koutsouleris N, Forsthoff A, Bruckmann K, Möller HJ, Meisenzahl EM. Schizophrenie: Effekte der pharmakoilogischen Behandlung mit Quetiapine auf zerebrale Aktivierungen – Eine fMRT Studie. KLIN NEUROPHYSIOL 2007. [DOI: 10.1055/s-2007-976447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
4
|
Forsthoff A, Grunze H, Seemüller F, Stampfer R, Dittmann S, Amann B, Schmidt F, Schäfer M, Hermle L, Walden J, Schreiner A. Risperidone monotherapy in manic inpatients: an open label, multicentre trial. World J Biol Psychiatry 2007; 8:256-61. [PMID: 17853251 DOI: 10.1080/15622970601169766] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
OBJECTIVE The efficacy of risperidone in acute mania has been established in several controlled clinical studies. However, this may not necessarily resemble the clinical effectiveness of this treatment, as patient populations in controlled studies are considered as being not representative. This study examined risperidone monotherapy in a sample of severe manic patients in admission ward settings. METHODS Open label monotherapy with risperidone was examined for 3 weeks in 30 inpatients. Subjects were evaluated with structured clinical rating scales: Young Mania Rating Scale (YMRS), Clinical Global Impression, bipolar version (CGI-BP), and the Extrapyramidal Symptom Rating Scale (ESRS). In addition, the amount of concomitant use of benzodiazepines was documented. Data were analysed using a last observation carried forward method on all subjects given medication at baseline. RESULTS Significant improvement from baseline to exit was observed both for the YMRS and CGI-BP. Responder analysis revealed that two-thirds of the patients showed a reduction of 50% in the YMRS score, and 69% of the patients were rated as very much improved or much improved on the CGI-BP mania scale at study exit. Only three patients dropped out due to adverse events, in one case due to extrapyramidal symptoms. CONCLUSIONS The efficacy of risperidone in the acute treatment of mania as observed in controlled studies could be replicated in this open monotherapy study in a severely manic inpatient population. Considering the mean maximal dosage of 5.5+/-0.9 mg risperidone, the tolerability and safety profile appeared satisfactory.
Collapse
Affiliation(s)
- Anna Forsthoff
- Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Abstract
The Internet has a powerful effect on society and thereby also on psychiatric patients. It offers suicide prevention services but also is a source of information and exchange of thoughts on how to commit suicide. This paper describes an 18-year-old female who learned about methods of suicide in the Internet and then ordered barbiturates. She survived because of early intervention.
Collapse
Affiliation(s)
- A Forsthoff
- Psychiatrische Klinik der Universität München.
| | | | | | | |
Collapse
|
6
|
Bernhard B, Schaub A, Kümmler P, Dittmann S, Severus E, Seemüller F, Born C, Forsthoff A, Licht RW, Grunze H. Impact of cognitive-psychoeducational interventions in bipolar patients and their relatives. Eur Psychiatry 2006; 21:81-6. [PMID: 16380236 DOI: 10.1016/j.eurpsy.2005.09.007] [Citation(s) in RCA: 28] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/14/2005] [Accepted: 09/13/2005] [Indexed: 02/05/2023] Open
Abstract
BACKGROUND In recent years, several controlled studies could show that psychoeducational interventions have been effective for relapse prevention in bipolar disorders. We therefore established a cognitive-psychoeducational group intervention with 14 sessions providing information about the illness, early warning signs, cognitive and behavioural strategies for stress management and social rhythm. Additionally we offered a group intervention for the patients' relatives. The objective of this study was to describe the outcome associated with our psychoeducational intervention in bipolar patients and their relatives. METHODS Sixty-two bipolar patients attended 14 sessions (à 90 min) of cognitive-psychoeducational group therapy. Patients' knowledge of bipolar disorder and their satisfaction with the treatment were assessed using self-developed questionnaires before and after the group intervention. Additionally, 49 relatives of bipolar patients received two psychoeducational workshops of 4 hours each. We assessed demographic variables, burden, high expressed emotion and depressive symptoms of the relatives before and after the two workshops and at 1-year follow-up. RESULTS Patients significantly improved their knowledge of bipolar disorder. They also have benefited from the discussions and the exchange of useful coping strategies. Burden and high expressed emotions showed no significant reductions at post-assessment, however they were significantly reduced at 1-year follow-up. Relatives also felt significantly better informed about the illness. CONCLUSIONS These findings show that psychoeducational interventions in bipolar patients and their relatives improve patients' and their relatives' knowledge of the illness and the burden of the disorder as well as high expressed emotions are reduced in relatives at 1-year follow-up.
Collapse
Affiliation(s)
- Britta Bernhard
- Bipolar Disorder Program, Department of Psychiatry and Psychotherapy, Ludwig-Maximilians-University, Nussbaumstrasse 7, 80806 Munich, Germany.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
7
|
Seemüller F, Forsthoff A, Dittmann S, Born C, Bernhard B, Severus WE, Grunze H. The safety and tolerability of atypical antipsychotics in bipolar disorder. Expert Opin Drug Saf 2005; 4:849-68. [PMID: 16111448 DOI: 10.1517/14740338.4.5.849] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Atypical antipsychotics (aAPs), have become a first-line treatment option, both in schizophrenia and bipolar disorders. Almost all aAPs now have proven efficacy in acute mania, some also in bipolar depression and in maintenance treatment. This provides reliable data on their safety and tolerability in this particular group of patients. This review focuses on the safety and tolerability of aAPs in the treatment of bipolar disorders. Both tolerability, for example, extrapyramidal symptoms, and safety issues, for example, occurrence of weight gain and hyperglycaemia, will be highlighted for olanzapine, quetiapine, risperidone, ziprasidone and aripiprazole.
Collapse
Affiliation(s)
- Florian Seemüller
- Department of Psychiatry, Ludwigs-Maximilians-University, Nussbaumstr. 7, 80336 Munich, Germany
| | | | | | | | | | | | | |
Collapse
|
8
|
Forsthoff A, Born C, Grunze H. [Puzzling bipolar disorder]. MMW Fortschr Med 2005; 147 Spec No 2:32-6. [PMID: 15968870 DOI: pmid/15968870] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Despite many advances in making the diagnosis of bipolar disorder, five to twelve years lie between the first affective episode and the introduction of an effective treatment. However, it is estimated that approximately only one-fourth of the patients with bipolar disorder are recognized as such at all. Clinical experience plays an important role in the diagnosis. Manias are often the cause for the first treatment with drugs, but the daily lives of patients with bipolar depression are often clearly more negatively affected. The acute therapy of bipolar depression is more complicated than that of mania and the difficult long-term treatment is always associated with a high suicide risk. A long-term therapy of bipolar disorders is not only meaningful for the prevention of new disease episodes, but also because it has a positive effect on comorbidities.
Collapse
Affiliation(s)
- A Forsthoff
- Klinik und Poliklinik für Psychiatrie, LMU München.
| | | | | |
Collapse
|
9
|
Abstract
Bipolar disorder is a common, recurrent, often severe mental disorder that, without adequate treatment, is associated with high rates of morbidity and mortality. We review the evidence on the efficacy of a spectrum of antiepileptic drugs (AED) in bipolar disorder. Most studies have been carried out with carbamazepine (CBZ), valproate (VPA), and lamotrigine (LTG). All three of these AEDs have been shown to be of value in the management of patients with bipolar illnesses. VPA and CBZ seem to exert stronger antimanic effects and, to a lesser degree, acute antidepressant efficacy. LTG seems to be effective against depression and mania, with a more robust activity against depression. No firm evidence supports a role for vigabatrin, tiagabine, topiramate, or levetiracetam in these disorders.
Collapse
Affiliation(s)
- Prashant Gajwani
- NIMH Bipolar Research Center, Case Western Reserve University School of Medicine, Mood Disorders Program, University Hospitals of Cleveland, OH, USA
| | | | | | | | | | | | | | | |
Collapse
|
10
|
Grunze H, Sasse J, Forsthoff A, Bauer M. [Bipolar disorders--how to recognize and treat them]. MMW Fortschr Med 2004; 146 Spec No 2:4-6, 8. [PMID: 15376694 DOI: pmid/15376694] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
Bipolar disorders are often diagnosed too late with an average of ten years elapsing between the first disease episode and the correct diagnosis and treatment. The most common misdiagnoses are unipolar depression, schizophrenia and ADHD (Attention Deficit Hyperactivity Disorder). The suicide rate associated with bipolar disease is very high. Treatment consists in the administration of mood stabilizers, in the first instance lithium, but also atypical neuroleptics or lamotrigine. In the depressive phase, additional antidepressants or lamotrigine, in the manic phase valproate or an antipsychotic agent may be needed. Medication must be continued unchanged for several months beyond acute treatment. The subsequent relapse prophylaxis depends on effectiveness, tolerability, comorbidity, suicidal risk and compliance. Pharmacotherapy is supplemented by psychotherapy and psycho-education.
Collapse
Affiliation(s)
- H Grunze
- Klinik und Poliklinik für Psychiatrie, LMU München.
| | | | | | | |
Collapse
|
11
|
Bauer M, Forsthoff A, Baethge C, Adli M, Berghöfer A, Döpfmer S, Bschor T. Lithium augmentation therapy in refractory depression-update 2002. Eur Arch Psychiatry Clin Neurosci 2003; 253:132-9. [PMID: 12904977 DOI: 10.1007/s00406-003-0430-9] [Citation(s) in RCA: 63] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 05/07/2003] [Indexed: 10/26/2022]
Abstract
Lithium has been used to augment the efficacy of antidepressant medications for more than 20 years. The present study examines whether evidence exists to support the clinical efficacy of lithium augmentation in refractory, treatment resistant depression. Studies were identified by searching Medline (1980 to August 2002) and by scanning the references of published reviews and standard textbooks. Studies were selected if they were open-labeled or double-blind, placebo-controlled or comparator trials that involved patients who had not responded to conventional antidepressants. 27 prospective studies were identified that included a total of 803 depressed patients displaying the following designs: 10 double-blind, placebo-controlled trials, 2 randomized, double-blind comparator trials, 2 randomized, open comparator trials, and 13 open-label trials. The majority of randomized controlled trials has demonstrated substantial efficacy of lithium augmentation in partial and non responders to antidepressant treatment. In the placebo-controlled trials, the response rate in the lithium group was 45% and in the placebo group 18% (p<0.001). Summarizing all open and controlled studies, approximately 50% of patients responded to lithium augmentation within 4 weeks. In conclusion, lithium is the foremost and most well-documented augmentation strategy in refractory depression.Therefore, it should be considered a first-line treatment strategy in patients with major depression who do not adequately respond to standard antidepressants.
Collapse
Affiliation(s)
- Michael Bauer
- Klinik fur Psychiatrie und Psychotherapie, Charite Campus Mitte Humboldt-Universitat zu Berlin, Schumannstr. 20-21, 10117, Berlin, Germany,
| | | | | | | | | | | | | |
Collapse
|
12
|
Schärer LO, Hartweg V, Valerius G, Graf M, Hoern M, Biedermann C, Walser S, Boensch A, Dittmann S, Forsthoff A, Hummel B, Grunze H, Walden J. Life charts on a palmtop computer: first results of a feasibility study with an electronic diary for bipolar patients. Bipolar Disord 2002; 4 Suppl 1:107-8. [PMID: 12479693 DOI: 10.1034/j.1399-5618.4.s1.51.x] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- L O Schärer
- Department of Psychiatry, University of Freiburg, Freiburg, Germany
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Dittmann S, Biedermann NC, Grunze H, Hummel B, Schärer LO, Kleindienst N, Forsthoff A, Matzner N, Walser S, Walden J. The Stanley Foundation Bipolar Network: results of the naturalistic follow-up study after 2.5 years of follow-up in the German centres. Neuropsychobiology 2002; 46 Suppl 1:2-9. [PMID: 12571425 DOI: 10.1159/000068018] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
The Stanley Foundation Bipolar Network (SFBN) is an international, multisite network investigating the characteristics and course of bipolar disorder. Methods (history, ratings and longitudinal follow-up) are standardized and equally applied in all 7 centres. This article describes demographics and illness characteristics of the first 152 German patients enrolled in the SFBN as well as the results of 2.5 years of follow-up. Patients in Germany were usually enrolled after hospitalisation. More than 72% of the study population suffered from bipolar I disorder and 25% from bipolar II disorder. The mean +/- SD age of the study participants was 42.08 +/- 13.5 years, and the mean +/- SD age of onset 24.44 +/- 10.9 years. More than 40% of the sample reported a rapid-cycling course in history, and even more a cycle acceleration over time. 37% attempted suicide at least once. 36% had an additional Axis I disorder, with alcohol abuse being the most common one, followed by anxiety disorders. During the follow-up period, only 27% remained stable, 56% had a recurrence, 12.8% perceived subsyndromal symptoms despite treatment and regular visits. 27% suffered from a rapid-cycling course during the follow-up period. Recurrences were significantly associated with bipolar I disorder, an additional comorbid Axis I disorder, rapid cycling in history, a higher number of mood stabilizers and the long-term use of typical antipsychotics. Rapid cycling during follow-up was only associated with a rapid-cycling course in history, a higher number of mood stabilizers and at least one suicide attempt in history.
Collapse
Affiliation(s)
- S Dittmann
- Department of Psychiatry, University of Munich, Munich, Germany.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
14
|
Hummel B, Dittmann S, Forsthoff A, Matzner N, Amann B, Grunze H. Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders. A case series. Neuropsychobiology 2002; 45 Suppl 1:37-42. [PMID: 11893876 DOI: 10.1159/000049260] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Atypical neuroleptics are increasingly used in the treatment of bipolar and schizoaffective disorders. Currently, numerous controlled short-term studies are available for clozapine, olanzapine, risperidone or quetiapine, but long-term data are still missing. Three patients (2 with bipolar disorder, 1 with schizoaffective disorder) are described who showed a marked reduction of affective symptomatology after clozapine had been added to mood stabilizer pretreatment. The patients were seen once a month before and after the introduction of clozapine for at least 6 months. Treatment response was evaluated using different rating scales (IDS, YMRS; GAF; CGI-BP) and the NIMH Life Chart Methodology. All patients showed a marked improvement after the add-on treatment with clozapine had been initiated. Clozapine was tolerated well with only transient and moderate weight gain and fatigue as only side effects. This case series underlines the safety and efficacy of clozapine as add-on medication in the treatment of bipolar and schizoaffective disorders.
Collapse
Affiliation(s)
- B Hummel
- Department of Psychiatry, LMU University Hospital, Munich, Germany
| | | | | | | | | | | |
Collapse
|
15
|
Forsthoff A, Mehnert P, Neffgen H. Comparison of laboratory studies with predictions of the required sweat rate index (ISO 7933) for climates with moderate to high thermal radiation. Appl Ergon 2001; 32:299-303. [PMID: 11394471 DOI: 10.1016/s0003-6870(01)00005-9] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
For International Standard ISO 7933 (Hot environments-analytical determination and interpretation of thermal stress using calculation of required sweat rate. International Organization for Standardization, Geneva, 1989) it has been questioned whether the heat stress index "required sweat rate" is applicable in environments where mean radiant temperature (t(r)) exceeds dry air temperature (t(a)). Based on a re-analysis of 556 climatic chamber experiments on 16 subjects the observed sweat rates were compared with required sweat rates predicted according to the ISO standard. Under climatic conditions with t(r) > t(a) the predictions overestimate the observed sweat rates on average by 86% in clothed subjects and by 25% in nude subjects. In climates with t(r) = t(a) the predictions highly agreed with the observed sweat rates in nude subjects and were slightly overestimated (13%) in clothed subjects. The misjudgement of the present ISO standard is obviously caused by an inappropriate calculation of radiative heat exchange. Corrections are proposed to improve the validity concerning climates with t(r) > t(a).
Collapse
Affiliation(s)
- A Forsthoff
- Institut für Arbeitsphysiologie an der Universität Dortmund, Germany
| | | | | |
Collapse
|
16
|
Griefahn B, Forsthoff A. Technical note. Comparison between estimated worn clothing insulation and required calculated clothing insulation in moderately cold environments (0 degree C < or = ta < or = +15 degrees C). Appl Ergon 1997; 28:295-299. [PMID: 9414370 DOI: 10.1016/s0003-6870(96)00064-6] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
Six female and 33 male workers of the food industry (16-55 years), divided into three groups according to climatic conditions at the workplaces, were monitored during a typical shift. Fourteen subjects worked continuously in 0-7 degrees C, 18 in 13-15 degrees C and seven moved frequently between these climatic areas. Mean metabolic rates, heart rates, rectal temperatures and skin temperatures at the trunk and at the feet were similar between each of the three groups. Considerable differences between estimated clothing insulations worn and calculated required clothing insulations (IREQneutral) were statistically analyzed. The results suggest that--apart from a limited overestimation--this discrepancy is mainly related to the difference between time-adjusted averages of metabolic rates of the single activities and the respective daily minimum suggesting the need for an adequate weighting for the metabolic rates, particularly if workers are at least temporarily exposed to air temperatures of more than 7-13 degrees C.
Collapse
Affiliation(s)
- B Griefahn
- University of Dortmund, Department of Environmental Physiology and Occupational Medicine, Federal Republic of Germany
| | | |
Collapse
|
17
|
Forsthoff A, Neffgen H. An improved method for describing the effects of heat radiation on men. J Hum Ergol (Tokyo) 1996; 25:20-5. [PMID: 9551127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
At industrial workplaces radiant heat load is often the dominant heat stress factor. Based on 900 climatic chamber experiments on humans, this study was conducted to develop a physiologically validated index-method to evaluate climates with intensified heat radiation. A comparison shows that the international recommended heat stress indices are not suitable to evaluate such climates correctly. By application of the new index-method into the commonly used indices, the improvement for the prediction of thermal stress effects in view of climates with increased heat radiation is discussed.
Collapse
Affiliation(s)
- A Forsthoff
- Department of Environmental Physiology and Occupational Medicine, Universität Dortmund, Germany
| | | |
Collapse
|